“Managing Bevacizumab-Related Gastrointestinal Perforation In Hepatocellular Carcinoma (HCC) Patients: A Systematic Review”. The Review of Diabetic Studies (February 10, 2025): 1039–1048. Accessed February 1, 2026. https://diabeticstudies.org/index.php/RDS/article/view/1715.